Tag results:
lymphocytes
Immune Regulation News
Suppressive Effects of the Obese Tumor Microenvironment on CD8 T Cell Infiltration and Effector Function
[Journal of Experimental Medicine] The authors investigated the effects of obesity on CD8 T cells in mouse models and patients with endometrial cancer.
Immune Regulation News
Human Invariant Natural Killer T Cells Promote Tolerance by Preferential Apoptosis Induction of Conventional Dendritic Cells
[Haematologica] Dendritic cells were either generated from monocytes or isolated directly from blood of healthy donors or graft-versus-host disease patients and co-cultured in a mixed lymphocyte reaction with T cells obtained from healthy donors or transplantation bags.
Human Immunology News
Selective Delivery of Low-Affinity IL-2 to PD-1+ T Cells Rejuvenates Antitumor Immunity with Reduced Toxicity
[Journal of Clinical Investigation] Investigators observed that anti–PD-1 therapy depends on IL-2 signaling, which raised the possibility that a lack of IL-2 limited anti–PD-1–induced effector T cell expansion.
Immune Regulation News
Elongation Factor-2 Kinase Is a Critical Determinant of the Fate and Antitumor Immunity of CD8+ T Cells
[Science Advances] eEF-2K KO CD8+ T cells were more metabolically active and showed hyperactivation of the Akt-mTOR-S6K pathway.
Immune Regulation News
Aspirin Activates Resolution Pathways to Reprogram T Cell and Macrophage Responses in Colitis-Associated Colorectal Cancer
[Science Advances] The authors demonstrated that aspirin increased concentrations of the immune-regulatory aspirin-triggered (AT) specialized proresolving mediators, including AT-lipoxin A4 and AT-resolvin D1, in colonic tissues during inflammation-associated colorectal cancer.
Pulmonary Cell News
Nuclear Factor-Kappa B (NF-κB) Inhibition as a Therapeutic Target for Plant Nutraceuticals in Mitigating Inflammatory Lung Diseases
[Chemico-Biological interactions] Scientists discuss the medical value of nutraceuticals briefly and their ability to mitigate various inflammatory lung diseases through targeting inhibition of NF-κB.